CAIRO: A total of 157,000 Hepatitis C patients have been treated in 2015 using the locally-produced Sovaldi medicine, Deputy Head of High Committee to Combat Hepatitis Viruses Manal Hamdy told Youm7 Sunday.
Egypt has one of the highest infection rates of Hepatitis C in the world. The country has started a treatment regimen based on imported medications to the virus since 2014; it recently began to locally produce them at subsidized costs.
The number of registrant patients to receive treatment has reached thus far over 1.2 million, Hamdy said.
She added that there are some 15,000 patients who are currently receiving treatment; while around 132,000 others have been cured by the new medications.
In 2016, the ministry hopes to cure a total of 500,000 Hepatitis C patients across Egypt using the Egypt-made regimen, which will include the locally-produced Daklinza medicine, according to previous statements by Deputy Head of the National Committee to Combat Hepatitis Viruses Waheed Dous to Youm7.